FDA approves LEQEMBI IQLIK weekly injection to start early Alzheimer’s treatment

Eisai and Biogen said the at-home autoinjector can now be used from initiation through maintenance in the U.S., with launch planned for late August 2026.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.